Botox developer rues missing out on billions
Botox developer Alan Scott says he rues the day he handed over rights to the best-selling wrinkle-smoothing drug to a US company for just $4.5 million, saying he might have become a billionaire.
Botox has become a front-line weapon in cosmetic medicine for erasing wrinkles -- while therapeutic applications of the drug are being used to help a wide variety of disorders from swallowing problems to muscle spasms.
"If I knew (how big it would become), I would have never given it to the drug company Allergan in 1991," Dr Alan Scott told the Times of India in an interview published on Monday.
"At present Botox is being used for over 100 disorders besides aesthetic applications," Scott said in New Delhi where he was en route to a conference in southern India.
The San Francisco opthalmologist said he got around $4.5 million for handing over the rights to the drug to the California-based company Allergan which "was then a satisfactory deal."
"But if I had held on to Botox, maybe I could have made a billion dollars a year now," Scott said.
Botox, which makes muscles relax, is a purified form of a nerve poison produced by a bacteria that causes a disease that paralyses muscles and can be fatal.
Botox was first approved in 1989 to treat two eye muscle disorders -- uncontrollable blinking and misaligned eyes.
"Initially when I developed it, I knew it could do wonders for neurological disorders. However, I had absolutely no idea it could work so well as a cosmetic agent," said Scott, who initially called the drug Oculinum.
The big cosmetic breakthrough came when Canadian ophthalmologist Dr. Jean Carruthers noticed her patients were starting to lose their frown lines and published a study in 1992.
A decade later Botox was approved as a frown fixer by the US Food and Drug Administration and now it is used in 80 countries.
Does Scott worry about any side-effects from the widespread use of Botox?
"It is not clear what will happen after decades of use. Maybe the facial muscles will weaken and sag. But we know that it works in reducing facial wrinkles," he said.
"Most women don't care what will happen years later. They just want the wrinkles to disappear now."
(c) 2012 AFP
- Botox reduces wrinkles even in less frequent doses Apr 26, 2010 | not rated yet | 0
- FDA approves Botox for migraine headaches Oct 15, 2010 | not rated yet | 0
- Study questions botox use for migraines Feb 08, 2011 | not rated yet | 0
- US approves Botox for bladder control Aug 24, 2011 | not rated yet | 0
- Dysport the newest wrinkle-stopping drug to hit market May 13, 2009 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
Medications 6 hours ago | not rated yet | 0
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications May 23, 2013 | 1 / 5 (1) | 0
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications May 23, 2013 | 5 / 5 (1) | 0
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications May 22, 2013 | not rated yet | 0
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
7 hours ago | 5 / 5 (2) | 4
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
7 hours ago | not rated yet | 1
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
7 hours ago | not rated yet | 0
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
23 hours ago | 3 / 5 (2) | 0 |
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
22 hours ago | not rated yet | 0
Kate O'Reilly's spring allergy survival kit includes the usual stuff - nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line of defense: an app on her smartphone.
23 hours ago | not rated yet | 0